Robeco Institutional Asset Management B.V. Crispr Therapeutics Ag Transaction History

Robeco Institutional Asset Management B.V.

$49.7 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$22.73 - $42.34 $339,768 - $632,898	-14,948 Closed	0 $0
Q3 2018 Oct 31, 2018	SELL	$44.35 - $65.71 $712,438 - $1.06 Million	-16,064 Reduced 51.8%	14,948 $663,000
Q2 2018 Aug 03, 2018	BUY	$42.62 - $73.59 $1.32 Million - $2.28 Million	31,012 New	31,012 $1.82 Million

Others Institutions Holding CRSP

# of Institutions

491

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

Capital International Investors Los Angeles, CA

7.93M
Shares

$406 Million
0.07% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$384 Million
3.35% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$153 Million
0.01% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$152 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$152 Million
1.61% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account